ON THIS PAGE:

 

Building a Healthier Future: Gavi’s Lifesaving Mission

Investment Opportunity

Gavi's Investment Opportunity 2026–2030

Gavi's Investment Opportunity 
2026–2030

Investing in Gavi’s next strategic cycle gives donors a unique opportunity to help to improve the health of people in the world’s lowest-income countries, strengthening global health security in turn.

Explore the Investment Opportunity


Also available in:

Arabic Chinese French German Italian Japanese Portuguese Spanish

Executive summaries:

Arabic Chinese English German Italian Japanese Korean Portuguese Spanish

See also:

Early supporters

Gavi is grateful to the new and returning donors that have already announced their pledges for Gavi's 2026–2030 strategic period.

About the Summit

A woman holding her child during a vaccination session. Credit: Gavi

Gavi’s High-Level Pledging Summit 2025 to be co-hosted by the European Union and the Gates Foundation

The high-level pledging summit, culminating Gavi’s 6.0 replenishment cycle, will be co-hosted in Brussels by the European Union and the Gates Foundation. The event will bring together global leaders from government, partner organisations, vaccine manufacturers, civil society and the private sector to secure crucial investments in life-saving immunsation programmes.

About the Pledging Summit

Voices of support

Gavi is one of the most successful development initiatives in history, protecting people and communities around the world since 2000. With the launch of Gavi's Investment Opportunity 2026–2030, leaders from government, partner organisations, civil society and business express why immunisation matters.

Hear from our Champions

Voices of Support for Gavi

About Gavi

The Vaccine Alliance plans to accelerate its impact between 2026–2030

leveraging the latest innovations in vaccines and vaccine delivery to protect 500 million children and saving over 8 million lives

IO1IO2IO3

Explore the Investment Opportunity

Discover our mission

As part of its mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 1.1 billion children in 78 lower-income countries, preventing more than 18.8 million future deaths.

Learn more

As part of its mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines, Gavi has helped vaccinate more than 1.1 billion children in 78 lower-income countries, preventing more than 18.8 million future deaths.

Learn more

Launch of the Investment Opportunity

The Global Forum for Vaccine Sovereignty and Innovation

On 20 June 2024, Gavi co-hosted the Forum alongside the African Union and the French Republic, launching its Investment Opportunity and the African Vaccine Manufacturing Accelerator (AVMA), an innovative financing mechanism which aims to foster regional vaccine production and vaccine sovereignty on the African continent.

Learn more about the Forum

AVMA: what is it and why is it important?

Watch the full event

 

Stay connected

Subscribe to our newsletter

Contact us

FAQs

What is the 'Health & Prosperity through Immunisation' Summit and why is it important?

The event will bring together global leaders from government, partner organisations, vaccine manufacturers, civil society and the private sector to secure crucial investments in life-saving immunsation programmes. 

A successful replenishment for Gavi will enable the Vaccine Alliance to implement its most impactful strategic period ever. Outcomes, as set out in Gavi’s Investment Opportunity, are expected to include: immunising at least 500 million children; saving an additional 8–9 million lives; generating at least US$ 100 billion in economic benefits for Gavi implementing countries; unprecedented levels of co-financing, with implementing countries contributing US$ 4 billion towards the cost of immunisation programmes; and boosting global health security by responding to 150 disease outbreaks. 

When will this event take place?

The event will take place on 25 June 2025, timings to be confirmed in the agenda closer to the event.  

Last updated: 9 May 2025